Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Adicet Bio, Inc. Director's Dealing 2019

May 10, 2019

34412_dirs_2019-05-09_fa5adb4f-82d1-4b05-80f9-bb2f5ae08537.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: resTORbio, Inc. (TORC)
CIK: 0001720580
Period of Report: 2019-05-08

Reporting Person: FONTEYNE PAUL R. (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-05-08 Stock Option (Right to Buy) $7.99 A 14414 Acquired 2029-05-07 Common Stock (14414) Direct

Footnotes

F1: This option was granted on May 8, 2019 with respect to 14,414 shares of Common Stock and vests in full on the earlier to occur of (a) the first anniversary of the grant date or (b) the date of the next annual meeting of stockholders following the date of grant.